Targeted radionuclide therapy with RAFT-RGD radiolabelled with 90Y or 177Lu in a mouse model of $\alpha$v$\beta$3-expressing tumours.,
, Eur. J. Nucl. Med. Mol. Imaging, Volume 42, Number 2, p.252–263, (2015)
Development of a selective cell capture and release assay: impact of clustered RGD ligands.,
, J. Mater. Chem. B Mater. Biol. Med., Volume 5, Number 24, p.4745–4753, (2017)